Stone House Investment Management LLC cut its position in MakeMyTrip Limited (NASDAQ:MMYT – Free Report) by 40.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 300 shares of the technology company’s stock after selling 200 shares during the period. Stone House Investment Management LLC’s holdings in MakeMyTrip were worth $28,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of MMYT. Baillie Gifford & Co. lifted its position in shares of MakeMyTrip by 85.7% during the second quarter. Baillie Gifford & Co. now owns 4,072,452 shares of the technology company’s stock valued at $342,493,000 after purchasing an additional 1,879,726 shares in the last quarter. FMR LLC grew its stake in MakeMyTrip by 51.2% in the 3rd quarter. FMR LLC now owns 3,635,473 shares of the technology company’s stock valued at $337,917,000 after buying an additional 1,230,916 shares in the last quarter. Jennison Associates LLC increased its position in shares of MakeMyTrip by 282.4% during the third quarter. Jennison Associates LLC now owns 2,316,572 shares of the technology company’s stock valued at $215,325,000 after buying an additional 1,710,773 shares during the period. William Blair Investment Management LLC grew its position in shares of MakeMyTrip by 54.5% during the 2nd quarter. William Blair Investment Management LLC now owns 1,099,062 shares of the technology company’s stock valued at $92,431,000 after purchasing an additional 387,695 shares in the last quarter. Finally, Marshall Wace LLP grew its position in MakeMyTrip by 129.2% during the second quarter. Marshall Wace LLP now owns 956,172 shares of the technology company’s stock worth $80,414,000 after buying an additional 539,067 shares in the last quarter. 51.89% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of equities analysts have recently commented on MMYT shares. Bank of America increased their price target on shares of MakeMyTrip from $112.00 to $119.00 and gave the stock a “buy” rating in a report on Thursday, October 24th. StockNews.com lowered MakeMyTrip from a “hold” rating to a “sell” rating in a research note on Wednesday, November 20th.
MakeMyTrip Stock Up 4.0 %
MakeMyTrip stock traded up $4.35 during trading hours on Wednesday, hitting $114.25. 506,037 shares of the stock traded hands, compared to its average volume of 551,205. The company has a current ratio of 2.82, a quick ratio of 2.81 and a debt-to-equity ratio of 0.19. MakeMyTrip Limited has a one year low of $41.56 and a one year high of $114.69. The company has a market cap of $12.54 billion, a PE ratio of 62.43, a PEG ratio of 6.18 and a beta of 1.27. The firm’s 50-day moving average price is $102.58 and its two-hundred day moving average price is $93.13.
MakeMyTrip (NASDAQ:MMYT – Get Free Report) last released its earnings results on Wednesday, October 23rd. The technology company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.26 by $0.10. The business had revenue of $210.99 million for the quarter, compared to the consensus estimate of $214.90 million. MakeMyTrip had a return on equity of 11.54% and a net margin of 26.64%. During the same period in the previous year, the company posted $0.18 earnings per share. On average, research analysts forecast that MakeMyTrip Limited will post 1.29 EPS for the current year.
MakeMyTrip Profile
MakeMyTrip Limited, an online travel company, sells travel products and solutions in India, the United States, Singapore, Malaysia, Thailand, the United Arab Emirates, Peru, Colombia, Vietnam, and Indonesia. The company operates through three segments: Air Ticketing, Hotels and Packages, and Bus Ticketing.
Read More
- Five stocks we like better than MakeMyTrip
- What Does a Stock Split Mean?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- There Are Different Types of Stock To Invest In
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What Is WallStreetBets and What Stocks Are They Targeting?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for MakeMyTrip Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MakeMyTrip and related companies with MarketBeat.com's FREE daily email newsletter.